NO20071254L - Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav. - Google Patents

Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.

Info

Publication number
NO20071254L
NO20071254L NO20071254A NO20071254A NO20071254L NO 20071254 L NO20071254 L NO 20071254L NO 20071254 A NO20071254 A NO 20071254A NO 20071254 A NO20071254 A NO 20071254A NO 20071254 L NO20071254 L NO 20071254L
Authority
NO
Norway
Prior art keywords
irbesartan
intermediates
preparation
formula
Prior art date
Application number
NO20071254A
Other languages
English (en)
Inventor
Edgar I Miranda
Cornelis Vlaar
Jingyang Zhu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20071254L publication Critical patent/NO20071254L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

En fremgangsmåte for fremstilling av irbesartan og mellomprodukter derav. Irbesartan har strukturen med formel I,
NO20071254A 2004-08-23 2007-03-07 Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav. NO20071254L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60360604P 2004-08-23 2004-08-23
PCT/US2005/029879 WO2006023889A2 (en) 2004-08-23 2005-08-23 A method for preparing irbesartan and intermediates thereof

Publications (1)

Publication Number Publication Date
NO20071254L true NO20071254L (no) 2007-03-22

Family

ID=35968277

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071254A NO20071254L (no) 2004-08-23 2007-03-07 Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.

Country Status (21)

Country Link
US (2) US7211676B2 (no)
EP (1) EP1781627B1 (no)
JP (1) JP5203703B2 (no)
KR (1) KR101252309B1 (no)
CN (1) CN101006064B (no)
AR (1) AR050709A1 (no)
AT (1) ATE488508T1 (no)
AU (1) AU2005277162B2 (no)
BR (1) BRPI0514584A (no)
CA (2) CA2754633A1 (no)
DE (1) DE602005024819D1 (no)
ES (1) ES2357393T3 (no)
HK (1) HK1098157A1 (no)
IL (1) IL181464A (no)
MX (1) MX2007002030A (no)
NO (1) NO20071254L (no)
PE (1) PE20060650A1 (no)
RU (1) RU2388753C2 (no)
TW (1) TWI346108B (no)
WO (1) WO2006023889A2 (no)
ZA (1) ZA200701363B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918288A1 (en) 2006-11-02 2008-05-07 Cadila Pharmaceuticals Limited A novel and improved process for the preparation of Irbesartan, an angiotensin-II receptor antagonist for the treatment of hypertension
GB0700993D0 (en) * 2007-01-18 2007-02-28 Rainbow Engineering Services Novel compounds
WO2008107799A2 (en) * 2007-03-06 2008-09-12 Actavis Group Ptc Ehf Improved process for preparing irbesartan
SI22488A (sl) * 2007-04-24 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalni 1-(cikloheksiloksikarboniloksi)etil 1-((2'-cianobifenil-4-il)metil) - 2-etoksi-1h-benz(d)imidazol -7-karboksilat in proces za njegovo pripravo
HUP0900788A2 (en) * 2009-12-16 2011-11-28 Sanofi Aventis Process for producing 4-bromomethyl-biphenyl derivatives
BR122017023130B1 (pt) * 2010-03-12 2018-03-06 Nippon Soda Co., Ltd. Derivado de tetrazoliloxima, métodos de produção de derivados de tetrazoliloxima
CN102807564A (zh) * 2012-08-30 2012-12-05 珠海润都制药股份有限公司 厄贝沙坦的制备方法
CN102898420B (zh) * 2012-09-10 2014-10-29 珠海保税区丽珠合成制药有限公司 一种厄贝沙坦的合成路线及制备方法
CN103497178B (zh) * 2013-09-27 2015-04-08 中国药科大学 厄贝沙坦瑞格列奈共无定型物
CN104744303B (zh) * 2015-02-15 2017-06-23 北京欣奕华科技有限公司 2‑r‑4’‑溴甲基联苯及其制备方法
CN108164434A (zh) * 2017-12-27 2018-06-15 安徽太主科技发展有限公司 一种低成本4′-溴甲基-2-氰基联苯的制备方法
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
IE910913A1 (en) * 1990-03-20 1991-09-25 Sanofi Sa N-substituted heterocyclic derivates, their preparation¹and pharmaceutical compositions containing them
US5541209A (en) 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
FR2725987B1 (fr) 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
JP3003030B2 (ja) * 1997-05-26 2000-01-24 武田薬品工業株式会社 アミノベンゼン化合物の製造法
FR2766821A1 (fr) 1997-07-29 1999-02-05 Sanofi Sa Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
CN100418962C (zh) * 2002-10-28 2008-09-17 南京长澳医药科技有限公司 一种厄贝沙坦合成工艺
DE602004014321D1 (de) * 2003-01-16 2008-07-24 Teva Pharma Neue synthese von irbesartan

Also Published As

Publication number Publication date
MX2007002030A (es) 2007-03-28
AU2005277162A1 (en) 2006-03-02
TWI346108B (en) 2011-08-01
CN101006064A (zh) 2007-07-25
ES2357393T3 (es) 2011-04-26
KR101252309B1 (ko) 2013-04-08
EP1781627B1 (en) 2010-11-17
US20060041147A1 (en) 2006-02-23
DE602005024819D1 (de) 2010-12-30
IL181464A0 (en) 2007-07-04
ATE488508T1 (de) 2010-12-15
RU2388753C2 (ru) 2010-05-10
JP2008510819A (ja) 2008-04-10
US7211676B2 (en) 2007-05-01
HK1098157A1 (en) 2007-07-13
TW200619205A (en) 2006-06-16
CN101006064B (zh) 2011-01-26
PE20060650A1 (es) 2006-07-09
CA2754633A1 (en) 2006-03-02
US20070167634A1 (en) 2007-07-19
EP1781627A2 (en) 2007-05-09
WO2006023889A3 (en) 2006-09-08
CA2578409A1 (en) 2006-03-02
US7365208B2 (en) 2008-04-29
IL181464A (en) 2011-08-31
AU2005277162B2 (en) 2010-12-16
RU2007109330A (ru) 2008-09-27
ZA200701363B (en) 2008-06-25
EP1781627A4 (en) 2009-09-02
WO2006023889A2 (en) 2006-03-02
AR050709A1 (es) 2006-11-15
BRPI0514584A (pt) 2008-06-17
KR20070045275A (ko) 2007-05-02
JP5203703B2 (ja) 2013-06-05

Similar Documents

Publication Publication Date Title
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
UA90706C2 (ru) Антагонисты рецептора pgd2 для лечения воспалительных заболеваний
WO2006092213A8 (de) Pyrazolylcarboxanilide
NO20084583L (no) Makrosykliske kinase-inhibitorer
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
ATE483000T1 (de) Naphtalin-amidin-imide
NO20092762L (no) 2-aza-bicyklo[3.1.0]heksanderivater
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20082266L (no) Nye 1-azabicykloalkylderivater for behandling av psykotiske og neurodegenerative forstyrrelser
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
GB0508318D0 (en) Organic compounds
UA104438C2 (uk) Спосіб одержання дабігатрану і його проміжних сполук
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
NO20082209L (no) Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer
TN2010000045A1 (en) Novel herbicides
NO20082118L (no) Heterocykliske CETP-inhibitorer
TW200745039A (en) Isotopically substituted pantoprazole
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MXPA05011962A (es) Oxiarenos substituidos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application